“Pan-coronavirus” vaccines: RNA Polymerase Emerges as a Vaccine Target

Resistance to COVID-19 infection has been observed in health care workers and has been attributed to the presence of memory T cells that target the RNA polymerase in the RTC (replication transcription complex), thereby preventing infection. This makes RNA polymerase an important target for making a pan-coronavirus vaccine that will be effective against SARS-CoV-2 and its other variants of concern (VoC’s), but also against the family of Coronaviruses in general. 

COVID-19 pandemic is now almost 2 years old and has caused havoc among the world by disrupting world economy and halting the normal way of living. Millions have died and many more have been infected with the disease leading to high levels of morbidity. However, there have been instances where people have cleared the infection from the system so quickly that they didn’t test positive for the virus or developed antibodies against it. This resistance has been attributed to the memory T cells-possibly those that are produced after exposure of the human system to such viruses

In a recent study published in Nature by Swalding et al., blood samples from 60 health care workers, who were at high risk of developing COVID-19 due to their exposure, were examined and found out to be negative for the virus and for the antibodies against the virus1. It is hypothesised that pre-existing memory T-cells, with cross-protective potential against SARS-CoV-2, expand in vivo to provide rapid viral clearance, thus aborting infection. These T cells are directed against the RNA polymerase in the RTC (replication transcription complex), rather than any other structural protein of the virus. These memory T cells could have been generated in the health care workers by being exposed to other respiratory or related corona viruses, albeit there is no direct evidence of the same. It is also possible that there were other environmental triggers that led to the generation of these T cells. In addition, these sero-negative individuals also showed an increase in IFI27, a protein indicative of abortive SARS-CoV-2 infection. IFI27 is an interferon alpha inducible protein that is overexpressed upon exposure to a variety of respiratory viruses, including SARS-CoV-2. This may also be responsible for viral clearance in individuals, pre-exposed to other respiratory viruses, and then infected with SARS-CoV-2. 

The fact that the memory T cells are directed against the RNA polymerase (being the most conserved among the human coronaviruses that cause common cold and SARS-CoV-2), makes this enzyme an important target to develop a pan-coronavirus vaccine that would not only be directed against SARS-CoV-2 and its other variants of concern (VoC’s) that have evolved as a result of mutations in the spike protein leading to more severe disease, but also against the family of Coronaviruses in general. 

*** 

Source:  

Swadling, L., Diniz, M.O., Schmidt, N.M. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature (2021). https://doi.org/10.1038/s41586-021-04186-8 

***

Latest

NASA Invites ISRO to Join Moon Base Programme

NASA has invited ISRO (Indian Space Research Organisation) to...

2026 Total Solar Eclipse

On 12 August 2026, a total solar eclipse was...

AI Designs Complete Functional Genomes

The genome language model Evo 2 has designed novel...

Voyager 2: The “Big Bang” Procedure Extends Life of Science Instruments

The “Big Bang” Energy-management procedure performed on Voyager 2...

A Black Hole That Is Not Formed from Stellar Collapse 

The black hole in the Little Red Dot (LRD)...

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30...

Newsletter

Don't miss

Generative Artificial Intelligence (AI): WHO issues new Guidance on governance of LMMs

WHO has issued new guidance on the ethics and...

The Nebra Sky Disk and ‘Cosmic Kiss’ Space Mission

The Nebra Sky Disk has inspired the logo of...

A New Approach to Treat Obesity

Researchers have studied an alternative approach to regulate immune...

A New Novel Way of Oxygen Production in Ocean

Some microbes in the deep-sea produce oxygen in a...

How Compensating Innovators Could Help Lift Lockdown due to COVID-19

For quicker lifting of lockdown, the innovators or entrepreneurs...

Green Tea Vs Coffee: The Former Seems Healthier

According to a study conducted among elderly in Japan,...
Rajeev Soni
Rajeev Sonihttps://web.archive.org/web/20220523060124/https://www.rajeevsoni.org/publications/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

NASA Invites ISRO to Join Moon Base Programme

NASA has invited ISRO (Indian Space Research Organisation) to join its “Moon Base programme” under Artemis Mission towards partnership in deep-space endeavour. This initiative to...

2026 Total Solar Eclipse

On 12 August 2026, a total solar eclipse was observed in the Northern Hemisphere across Greenland, Iceland, northern Russia, the Atlantic Ocean, Spain, and...

AI Designs Complete Functional Genomes

The genome language model Evo 2 has designed novel functional genomes of bacteriophage ΦX174. About 300 of the AI-generated designs were chemically synthesised and tested in...